Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 21 No 9 Sept/Oct 2016

Book of the Month

Cover of Goode on Commercial Law

Goode on Commercial Law

Edited by: Ewan McKendrick
Price: £170.00

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Regulating Risk: Values and Law in Health Research Governance

Image not available lge

ISBN13: 9780415816007
To be Published: April 2017
Publisher: Routledge
Country of Publication: UK
Format: Hardback
Price: £90.00

This book undertakes an exploration of the key concept of ‘values’ and particularly examines the significance of socio-moral values to the advancement of the field of biomedical law and research governance. Values serve as a touchstone throughout the book and the author seeks to identify the values which are present in the core international instruments relevant to biomedicine and considers the ways in which those values are defined and ranked. In the process, he critiques those core international instruments from a value perspective and demonstrates the policy tensions that exist in the biomedical field.

This book is international in scope but many of the examples cited are drawn from biomedical practise in the UK and Argentina. The UK is one of the most active jurisdictions in the field of biomedical research governance and often serves as a model for other jurisdictions. It is referenced here with a view to providing examples of the adoption of values influenced legal and ethical mechanisms which are now actively in force. By contrast, Argentina is an emerging economy relying on biomedicine as a means of sustainable development and national re-imagining, and in the process it is actively redesigning its regulatory environment. Argentina is a useful example of the challenges faced by, and potential courses open to, developing or emerging countries with obvious relevance to countries across Latin America. Harmon pulls together examples of values informing regulation in the UK and Argentina and from them offers a framework for regulating this dynamic field. The emphasis of the analysis of the regulation of the life sciences and biotechnology is on how that regulation puts into practise (or fails to put into practise) claimed socio-moral values.

Image not available lge
Medical Law
1. Introduction

Part 1: Health, Law and Socio-Moral Values
2. Our Confrontation with Reality
3. Our Summoning of the Law
4. Our Better Angels and the Value of Values

Part 2: Value Rhetoric in International Instruments Relevant to Biomedicine
5. Values in the International Human Subject Research Instruments
6. Values in the International Biomedical Research Instruments
7. Values in the International Commercial Instruments

Part 3: Case Study I – Values in the Operational Setting: A Case Study on Narrowing and Preferencing Values in the UK
8. Paradigms and Mechanisms in the Research Context: UK Biobank and Consent
9. Paradigms and Mechanisms in the Treatment Context: UK Courts and Tissue Control
10. Paradigms and Mechanisms in the Commercial Context: European Patent Cases and Ownership

Part 4: Case Study II – Values in the Pre-Law Setting: A Case Study on Values Held and Regulatory Objectives in Argentina
11. Argentina’s Evolving Legal Framework in Biomedicine
12. Values Claimed by Argentina’s Science and Policy Elites
13. Shaping Argentina’s Science Environment: Vindicating the Democracy Value Part 5: A Value-Conscious and Value-Based Framework
14. Conclusion: Operationalising Values in the Biomedical Context